In the month following his being honored with a prestigious award from the federal Health and Human Services (HHS) Secretary’s office, Wilson Compton, MD, has been named deputy director of the National Institute on Drug Abuse (NIDA). Compton has directed NIDA’s Division of Epidemiology, Services and Prevention Research since 2002.
Compton’s division at NIDA has encompassed research into the causes of drug abuse; development of prevention approaches; and strategies for implementing treatment initiatives. He recently has focused on launching a joint project with the Food and Drug Administration’s (FDA’s) Center for Tobacco Products to conduct a large-scale population study on the impact of new tobacco regulations.
“In more than a decade as a Division Director here at NIDA, he has built a formidable team supporting research into the extent and causes of substance abuse, with a strong focus on tobacco, prescription and illicit drug abuse,” NIDA Director Nora D. Volkow, MD, said of Compton in a Nov. 8 news release. “His passion is unwavering, and his enthusiasm to use science to find improved approaches to substance abuse management will inspire us all.”
Prior roles for Compton before joining NIDA included serving as medical director of addiction services at the Barnes-Jewish Hospital in St. Louis and directing the Psychiatric Epidemiology Program at Washington University.